One-Day liver cancer treatment shows promise in early trial

This early-phase study tests whether a liver cancer treatment called Y90 radioembolization can be safely done in a single session instead of the usual two-day process. The treatment uses tiny radioactive beads injected into the liver's blood supply to block tumor growth. Researchers want to see if this faster approach reduces patient travel and costs while keeping side effects manageable. The study includes 12 adults with liver cancer that has spread to other parts of the body.